A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.
Blood Adv
; 7(13): 2983-2993, 2023 07 11.
Article
in En
| MEDLINE
| ID: mdl-36809796
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tumor Lysis Syndrome
/
Lymphoma, Mantle-Cell
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Blood Adv
Year:
2023
Type:
Article